GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 52 filers reported holding GEMINI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,994,000 | -2.9% | 2,435,125 | 0.0% | 3.07% | +6.8% |
| Q2 2022 | $4,115,000 | +21.6% | 2,435,125 | 0.0% | 2.88% | +108.0% |
| Q1 2022 | $3,385,000 | -52.2% | 2,435,125 | 0.0% | 1.38% | -20.6% |
| Q4 2021 | $7,086,000 | -28.0% | 2,435,125 | 0.0% | 1.74% | -43.1% |
| Q3 2021 | $9,838,000 | -37.6% | 2,435,125 | 0.0% | 3.06% | -50.7% |
| Q2 2021 | $15,755,000 | -52.3% | 2,435,125 | 0.0% | 6.20% | -36.1% |
| Q1 2021 | $32,996,000 | – | 2,435,125 | – | 9.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $9,838,000 | 3.06% |
| Asymmetry Capital Management, L.P. | 284,079 | $1,148,000 | 0.69% |
| Orbimed Advisors | 5,826,224 | $23,538,000 | 0.26% |
| Boxer Capital, LLC | 1,300,000 | $5,252,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,137,823 | $8,637,000 | 0.15% |
| Ikarian Capital, LLC | 421,050 | $1,701,000 | 0.12% |
| JS Capital Management LLC | 474,457 | $1,917,000 | 0.11% |
| PURA VIDA INVESTMENTS, LLC | 494,400 | $1,997,000 | 0.06% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,010,000 | 0.06% |
| Atom Investors LP | 102,792 | $415,000 | 0.03% |